RightFit
RecruitingNot applicable

Use of CGM in Kidney Transplant Recipients

Continuous Glucose Monitoring (CGM) to Improve Glycemic Control in Kidney Transplant Recipients

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests whether continuous glucose monitoring (CGM), a device that tracks blood sugar, helps people with diabetes after a kidney transplant. It measures how much time blood sugar stays between 70 and 180 mg/dL. It is for adults with type 2 diabetes who use insulin and received a kidney transplant within the past year.

The investigators want to study the impact CGM (continuous glucose monitoring) has on patients glycemic control as determined by time in range (TIR 70-180 mg/dL) in the Diabetic Kidney Transplant population.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Age 18 or older.
  • Received a kidney transplant within the past year, with a working kidney and a kidney filtering score (eGFR) above 30 mL/min.
  • Have type 2 diabetes and use insulin.
  • Have Wi-Fi at home.

Who can't join

  • Have type 1 diabetes or take the medicine hydroxyurea.
  • Cannot wear the Dexcom G6 blood sugar monitor at all times.
  • Cannot check blood sugar with a meter 4 times a day while using a monitor that hides its readings.
  • Have serious problems with vision, memory, or thinking, or cannot read.
  • Are a prisoner.
  • Are pregnant, plan to become pregnant during the study, or are breastfeeding.
  • Have heart or blood vessel disease that is not stable.
  • Are currently receiving cancer treatment.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: 1. Age 18 or above 2. Received a kidney transplant within the past year with functioning kidney (eGFR \> 30 mL/min 3. Person with Type 2 Diabetes and on insulin 4. Access to home wi-fi connection Exclusion Criteria: 1. Person with Type 1 Diabetes 2. Patients taking hydroxyurea 3. Patient unable to wear the Dexcom G6 device at all times for any reason 4. Must be able to test blood glucose with meter 4x a day when on blinded CGM. 5. Presence of clinically significant visual or cognitive impairment 6. Illiterate 7. Prisoners 8. Women who are pregnant, who plan to become pregnant during the course of the study, or who are breastfeeding 9. Presence of clinically unstable cardiovascular disease 10. Active malignancy treatment

Study sites (1)

CA